MEDITECH(SH:603990) Shang Hai Zheng Quan Bao·2026-01-29 19:37Core Viewpoint - The company, Suzhou Mediston Medical Technology Co., Ltd., is forecasting a turnaround in its financial performance for the year 2025, expecting to achieve profitability after a loss in the previous year [2][3]. Group 1: Performance Forecast - The company anticipates a net profit attributable to shareholders of the parent company between 39 million and 44 million yuan for 2025, compared to a loss of approximately 279.47 million yuan in the previous year [2][3]. - The expected net profit after deducting non-recurring gains and losses is projected to be between 10 million and 15 million yuan [4]. - The performance forecast covers the period from January 1, 2025, to December 31, 2025 [2]. Group 2: Previous Year Performance - In 2024, the company reported a total profit of -253.73 million yuan, with a net loss attributable to shareholders of the parent company at -279.47 million yuan, and a net loss after deducting non-recurring gains and losses of -367.42 million yuan [6]. - The earnings per share for the previous year were -0.92 yuan per share [7]. Group 3: Reasons for Turnaround - The company attributes the expected turnaround to the completion of a significant asset sale, which involved divesting its photovoltaic business. This strategic move is part of a broader focus on core medical operations, enhancing asset-light attributes, and building a platform-based ecosystem [8]. - The company aims to optimize its business structure and improve operational stability through refined management practices, thereby enhancing profitability [8].